Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	16.27B
Revenue (ttm)	4.26B
Net Income (ttm)	887.85M
Shares Out	84.72M
EPS (ttm)	10.44
PE Ratio	18.39
Forward PE	12.96
Dividend	7.50 (3.88%)
Ex-Dividend Date	Mar 26, 2025

Volume	465,105
Average Volume	247,039
Open	192.00
Previous Close	193.50
Day's Range	188.00 - 192.00
52-Week Range	158.50 - 264.00
Beta	0.51
RSI	37.77
Earnings Date	Aug 11, 2025

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2024, TPEX:3218's revenue was 4.23 billion, an increase of 3.58% compared to the previous year's 4.08 billion. Earnings were 1.06 billion, an increase of 1.88%.